AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
First Tracks Biotherapeutics, Inc. Ordinary Shares
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG020RF4R28
44.05▲ 0.91 (2.11%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
—
EBITDA
—
Diluted EPS (TTM)
—
EBITDA Margin
—
Net Debt
—
Trading Information
Previous Close
43.14
Day's Range
41.60 – 44.78
52-Week Range
14.72 – 49.91
Volume
849.4K
Avg Volume
1.1M
Share Statistics
Shares Outstanding
Employees
—
Exchange
XNAS
Listed
2026-04-06
Share count as of August 7, 2026

First Tracks Biotherapeutics, Inc. Ordinary Shares (TRAX) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about First Tracks Biotherapeutics, Inc. Ordinary Shares (TRAX)
What is First Tracks Biotherapeutics, Inc. Ordinary Shares's Market Cap?
First Tracks Biotherapeutics, Inc. Ordinary Shares's Market Cap is $1.6B, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · TRAXAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Jun 30, 2025Mar 31, 2025
Operating expenses:
Research and development—
General and administrative—
Total operating expenses—
Loss from operations—
Other income (expense), net:
Interest income—
Other expense, net—
Total other income (expense), net—
Net loss
Net loss per common share, Baisc—
Net loss per common share, Diluted—